Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Becton Dickinson (NY: BDX )

235.24 +1.65 (+0.71%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Becton Dickinson

< Previous 1 2 3 4 5 6 7 8 9 Next >
2 Safe Dividend Growth Stocks You Can Buy and Forget About
These yields may seem low, but you'll likely be earning much more on your initial investment over time. 
Via The Motley Fool
Semiconductor Shortage Hits Supply Chain For MedTech Industry
According to a study commissioned by AdvaMed, the global semiconductor chip shortage is causing delays, order cancellations, and other supply disruptions at MedTech companies.... 
Via Benzinga
Why Biden's Action Plan Is Bullish For COVID-19 Testing Stocks
On Thursday, President Joe Biden revealed his new COVID-19 action plan, which includes $2 billion in government spending on 280 mi... 
Via Benzinga
Exposures COVID-19
Notable Becton Dickinson Insider Trades $5.72 Million In Company Stock
James Lim, Executive Vice President at Becton, Dickinson (NYSE:BDX), made a large buy and sell of company shares on September 3, according to a new SEC filing. What Happened... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
Why Shares of Quidel Surged 10% This Week
Demand for its COVID tests are rising with cases. 
Via The Motley Fool
ROCE Insights For Becton
Looking at Q2, Becton (NYSE:BDX) earned $434.00 million, a 65.03% increase from the preceding quarter. Becton's sales decreased to $4.91 billion, a 7.68% change since Q1. Becton... 
Via Benzinga
BD Locks FDA Emergency Use Nod For At-Home COVID-19 Antigen Test
The FDA has issued an Emergency Use Authorization (EUA) for Becton Dickinson and Co's (NYSE: BDX) BD Veritor At-Home COVID-19 Test. Also Read: BD... 
Via Benzinga
Exposures COVID-19 Product Safety
BD's Automated Molecular Diagnostics Platform Wins FDA Approval, Initial Test For HPV
Becton Dickinson and Co (NYSE: BDX) has received FDA approval for its automated, sample-to-answer, high-throughput BD Cor system along with the BD Onclarity HPV... 
Via Benzinga
Exposures Product Safety
'Halftime Report' Traders Share Their Thoughts On Leslie's, Zynga And More
On CNBC's "Fast Money Halftime Report," Josh Brown said he is still holding Leslie's Inc (NASDAQ: LESL) and he still believes in it. He may even add to his long... 
Via Benzinga
JPMorgan Downgrades Becton Dickinson On Muffled FY22 Outlook
JPMorgan downgraded Becton Dickinson and Co (NYSE: 
Via Benzinga
10 Biggest Price Target Changes For Friday
Piper Sandler boosted the price target for Moderna, Inc. (NASDAQ: MRNA) from $246 to $445. Moderna shares fell 1.6% to $409.55 in pre-market trading. Needham cut the price... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 6, 2021
Upgrades According to Wolfe Research, the prior rating for The AES Corp (NYSE: 
Via Benzinga
Becton, Dickinson and Company (BDX) Q3 2021 Earnings Call Transcript
BDX earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
BDX Stock Plunges Despite Q3 Earnings Topping Estimates On Recovery In Elective Volumes; Raised FY21 Guidance
Becton Dickinson and Co (NYSE: BDX) reported Q3 revenues of $4.9 billion, +26.9% Y/Y, better than the consensus of $4.51 billion. The increase is primarily driven by... 
Via Benzinga
Becton, Dickinson: Q3 Earnings Insights
Shares of Becton, Dickinson (NYSE:BDX) remained unaffected after the company reported Q3 results. Quarterly Results Earnings per share were up 24.55% year over year to $2.... 
Via Benzinga
Price Over Earnings Overview: Becton, Dickinson
Looking into the current session, Becton, Dickinson Inc. (NYSE:BDX) shares are trading at $257.45, after a 0.52% gain. Moreover, over the past month, the stock... 
Via Benzinga
3 Dividend Stocks Safe Enough to Bet the Farm On
You shouldn't invest your life savings into any one stock, but these three have some serious potential. 
Via The Motley Fool
2 Cheap Dividend Stocks You Can Buy Right Now
There's a good chance your dividend income will rise over the years with these two investments. 
Via The Motley Fool
4 Top Dividend Aristocrats To Add To Your Retirement Portfolio
Amid the current market volatility on concerns over rising inflation, we think it is wise to invest in the shares of dividend aristocrats, given their long history of increasing dividends. 
Via Talk Markets
Topics Retirement
Exposures Pension
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021
Upgrades For Appian Corp (NASDAQ:APPN), Macquarie upgraded the previous rating of Underperform to Neutral. For the first quarter, Appian had an EPS of $0.06, compared to... 
Via Benzinga
3 Dividend Stocks That Are Safer Investments Than AT&T
Low payout ratios and tons of cash make these stocks solid income investments that you can buy and forget about. 
Via The Motley Fool
15 Dividend Aristocrats For Long-Term Dividend Growth
The best dividend stocks to buy and hold over the long term have a number of key characteristics in common. They have leadership positions in their industry, which provides for steady profits each... 
Via Talk Markets
Topics Economy
Exposures Economy
Becton Dickinson To Build Fourth Facility In Spain To Expand Pre-Filled Drug Delivery Business
Becton Dickinson and Co (NYSE: BDX) will build a €165 million ($200 million) high-tech manufacturing facility in Zaragoza, Spain, that will create up to 600... 
Via Benzinga
MedTech Round Up: Update On Johnson & Johnson, Becton Dickinson, Labcorp, Second Sight Medical, Biocept
Johnson & Johnson's (NYSE: JNJ) Vision segment has won FDA approval for the first contact lenses designed to reshape the cornea curve and help treat... 
Via Benzinga
Exposures Product Safety
Becton Dickinson & Co. (BDX) Q2 2021 Earnings Call Transcript
BDX earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Becton Dickinson To Spin-Off Diabetes Care Business: Highlights
While reporting financial results for the second fiscal quarter of the year, during which revenues grew more than 15% to $4.9 billion, Becton Dickinson and Co... 
Via Benzinga
BDX Q2 Earnings Top Estimates, Reports $480M COVID-19 Diagnostic Sales; Reaffirms FY21 Guidance
Becton Dickinson and Co (NYSE: BDX) reported Q2 revenues of $4.91 billion, an increase of 15.4% Y/Y, slightly better than the consensus of $4.89 billion. The... 
Via Benzinga
Exposures COVID-19
Recap: Becton, Dickinson Q2 Earnings
Shares of Becton, Dickinson (NYSE:BDX) decreased 0.4% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 25.10%... 
Via Benzinga
SPACs Attack Recap: 5 Deals, Rumors And Headline News
It was another busy week for the SPAC market with numerous deal announcements and rumored deals. Benzinga's "SPACs Attack" covered it all throughout the week. Here... 
Via Benzinga
Bill Gates-Backed Vicarious Surgical Announces SPAC Deal With D8 Holdings: What You Need To Know
Vicarious Surgical Inc. announced a SPAC merger on Thursday that will bring the next-gen robotics company to the public markets. The SPAC Deal: Vicarious Surgical is going public... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.